cagrilintide semaglutide combination phase 3 2024 Cagrilintide–semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a randomised, double-blind, placebo-controlled, multicentre, study cagrisema cagrilintide semaglutide phase 3

Side effects at six months By the six-month mark, most GI side effects have resolved or become manageable

A lot of the evidence supporting this risk comes from case reports, when a doctor writes about a specific patients experience, not large-scale clinical trials

Liraglutide vs

Tip: Only order from licensed Canadian pharmacies that verify prescriptions

Bloating and Farting These uncomfortable side effects were reported in clinical trials as abdominal distension and flatulence. Bloating and farting complaints are less common than the gastrointestinal effects discussed above, and they have yet to catch on as hot topics on social media, but its good to know that Ozempic and related drugs may increase their likelihood